Topic · page 9 of 12

Across rheumatic diseases

Only studies that genuinely span several rheumatic diseases, such as drug safety and pharmacovigilance, infection, vaccination and comorbidity (cardiovascular, cancer, mental health) across diseases, and health services and quality of care across diseases. Never a fallback for an article that is hard to place

Briefs 321–360 of 474 placed here, newest publication first

Briefs in Across rheumatic diseases

Newest publication first

RMD Open29 Nov 2023
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
Cohort study
RMD Open29 Nov 2023
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series
Randomized controlled trial
RMD Open29 Nov 2023
Characteristics and outcome of critically ill patients with systemic rheumatic diseases referred to the intensive care unit
Cohort study
RMD Open23 Nov 2023
Involving patients as research partners in research in rheumatology: a literature review in 2023
Research article
Arthritis Care Res (Hoboken)23 Nov 2023
Summarizing Evidence of Associations of COVID‐19 With a Future Diagnosis of Inflammatory Rheumatic and Musculoskeletal Diseases: A Rapid Review
Research article
Semin Arthritis Rheum22 Nov 2023
mRNA vaccines in the rheumatologist's future
Research article
Joint Bone Spine22 Nov 2023
2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis
Guideline or statement
RMD Open16 Nov 2023
COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study
Cohort study
Lancet Rheumatol15 Nov 2023
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial
Cohort study
Rheumatology (Oxford)15 Nov 2023
The predictive accuracy of cardiovascular disease risk prediction tools in inflammatory arthritis and psoriasis: an observational validation study using the Clinical Practice Research Datalink
Diagnostic or prognostic study
Arthritis Care Res (Hoboken)14 Nov 2023
The Use of Remote Consultations and Associated Factors in Rheumatology: A Large Retrospective Cohort Study of Follow‐Up Consultations Before, During, and After COVID‐19
Cohort study
Clin Exp Rheumatol7 Nov 2023
Epstein-Barr virus infection and prognosis in haemophagocytic lymphohistiocytosis patients with underlying rheumatic diseases: a single-centre retrospective study
Cohort study
Arthritis Care Res (Hoboken)7 Nov 2023
Impact of Risk Factors on COVID‐19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID‐19 Global Rheumatology Alliance Registry
Cohort study
Semin Arthritis Rheum4 Nov 2023
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis
Meta-analysis
JAMA Netw Open1 Nov 2023
Control Groups in RCTs Supporting Approval of Drugs for Systemic Rheumatic Diseases, 2012-2022
Cross-sectional study
RMD Open31 Oct 2023
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases
Cohort study
Semin Arthritis Rheum29 Oct 2023
Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study
Case-control study
Semin Arthritis Rheum26 Oct 2023
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group
Guideline or statement
Rheumatology (Oxford)25 Oct 2023
Parental autoimmunity and offspring risks of rheumatic diseases: a nationwide population-based study
Cohort study
Clin Exp Rheumatol24 Oct 2023
Post-traumatic stress disorder and post-traumatic stress symptoms in patients with systemic autoimmune diseases during the COVID-19 pandemic
Cohort study
Lupus Sci Med17 Oct 2023
COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology
Cohort study
J Rheumatol15 Oct 2023
Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases
Cohort study
Arthritis Rheumatol28 Sep 2023
Body Mass Index and the Risk of Rheumatic Disease: Linear and Nonlinear Mendelian Randomization Analyses
Research article
Arthritis Care Res (Hoboken)22 Sep 2023
Long COVID in Persons With Self‐Reported Arthritis: Symptoms, Associated Factors, and Functional Limitations
Cross-sectional study
RMD Open21 Sep 2023
Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters
Diagnostic or prognostic study
Rheumatology (Oxford)21 Sep 2023
Paraneoplastic arthritis: a series of 92 cases
Cohort study
Rheumatology (Oxford)19 Sep 2023
Occupational impacts of early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit
Cohort study
J Rheumatol15 Sep 2023
Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years
Cohort study
Clin Exp Rheumatol12 Sep 2023
Dynamics of SARS-CoV-2 IgG antibodies and neutralising antibodies in rheumatic and musculoskeletal diseases patients with COVID-19
Cohort study
Rheumatology (Oxford)7 Sep 2023
Analgesic prescribing in patients with inflammatory arthritis in England: observational studies in the Clinical Practice Research Datalink
Cross-sectional study
J Rheumatol1 Sep 2023
Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network
Cross-sectional study
RMD Open31 Aug 2023
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study
Cohort study
Rheumatology (Oxford)30 Aug 2023
Baseline predictors of disease severity in immune checkpoint inhibitor-induced inflammatory arthritis
Cohort study
Arthritis Care Res (Hoboken)29 Aug 2023
Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs
Research article
Clin Exp Rheumatol25 Aug 2023
Association of anti-Ro52 antibody with depression and anxiety in patients with connective tissue diseases: an observational, single-centre, cross-sectional study
Cross-sectional study
Arthritis Rheumatol22 Aug 2023
Risk–Benefit Analysis of Primary Prophylaxis Against Pneumocystis Jirovecii Pneumonia in Patients With Rheumatic Diseases Receiving Rituximab
Cohort study
Semin Arthritis Rheum22 Aug 2023
Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis
Meta-analysis
RMD Open21 Aug 2023
Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
Meta-analysis
J Rheumatol15 Aug 2023
Symptom Appraisal and Help-Seeking Among Patients With Autoimmune Rheumatic Diseases: A Qualitative Study
Research article
RMD Open9 Aug 2023
Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network
Cohort study

All 474 Briefs in ExploreShowing Briefs 321–360 of 474, newest first